RAZELLE KURZROCK, M.D.
Osteopathic Medicine at Holcombe Blvd, Houston, TX
License number
Texas G6326
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about RAZELLE KURZROCK at radaris.comName
Address
Phone
805 Anderson St, Bellaire, TX 77401
Organization information
See more information about RAZELLE KURZROCK at bizstanding.comRazelle Kurzrock MD
1515 Holcombe Blvd, Houston, TX 77030
Industry:
Internist
Phone:
(713) 792-6161 (Phone)
Razelle Kurzrock
Professional information
Razelle Kurzrock, Houston TX
Specialties:
Internist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
University of Toronto, Faculty of Medicine - Doctor of Medicine
Tulane University Hospital & Clinic - Residency - Internal Medicine
Tulane University Hospital & Clinic - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Razelle Kurzrock, Houston TX
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Dr. Razelle Kurzrock, Houston TX - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
(713) 792-2121 (Phone)
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
(713) 792-2121 (Phone)
Certifications:
Hematology, 1994, Internal Medicine, 1983, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
Education:
Medical School
UNIVERSITY OF TORONTO / COLLEGE OF MEDICINE
Mt Sinai Hosp
Tulane U Affil Hosp
MD Anderson Hosp
UNIVERSITY OF TORONTO / COLLEGE OF MEDICINE
Mt Sinai Hosp
Tulane U Affil Hosp
MD Anderson Hosp
Liposomal Curcumin For Treatment Of Neurofibromatosis
US Patent:
2008010, May 1, 2008
Filed:
Oct 5, 2007
Appl. No.:
11/868251
Inventors:
RAZELLE KURZROCK - HOUSTON TX, US
LAN LI - HOUSTON TX, US
KAPIL MEHTA - HOUSTON TX, US
BHARAT AGGARWAL - HOUSTON TX, US
LAN LI - HOUSTON TX, US
KAPIL MEHTA - HOUSTON TX, US
BHARAT AGGARWAL - HOUSTON TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 31/12, A61P 25/00
US Classification:
514679000
Abstract:
The present invention provides a compositions and methods for the treatment of Neurofibromatosis Type 1 and 2, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system to target Merlin and proteins of the Merlin pathway. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.
Liposomal Curcumin For Treatment Of Cancer
US Patent:
2011028, Nov 24, 2011
Filed:
May 27, 2011
Appl. No.:
13/117807
Inventors:
Razelle Kurzrock - Houston TX, US
Lan Li - Houston TX, US
Kapil Mehta - Houston TX, US
Bharat B. Aggarwal - Houston TX, US
Lan Li - Houston TX, US
Kapil Mehta - Houston TX, US
Bharat B. Aggarwal - Houston TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 9/14, A61P 35/00, A61K 9/51, A61K 9/19, A61K 31/12, A61K 9/127
US Classification:
424450, 424489, 514679, 424501, 424451
Abstract:
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.